NFKB1
Overview
NFKB1 encodes a subunit of the NF-kB transcription factor complex. In the cbio-kb corpus it is nominated as a novel U-CLL driver linked to NF-kB signaling and adverse outcomes.
Alterations observed in the corpus
- U-CLL-specific novel driver in the 1,148-patient CLL map; recurrent somatic mutations linked to NF-kB signaling and adverse FFS/OS PMID:35927489.
Cancer types (linked)
- Chronic lymphocytic leukemia (CLLSLL) — novel U-CLL driver; candidate addition to CLL risk models PMID:35927489.
Co-occurrence and mutual exclusivity
- Enriched in IGHV-unmutated (U-CLL) subtype relative to M-CLL PMID:35927489.
Therapeutic relevance
- No direct therapeutic link reported in the corpus.
Open questions
- Functional validation as a CLL driver is deferred to future work PMID:35927489.
Sources
This page was processed by crosslinker on 2026-04-08.